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ABSTRACT: The par toxin-antitoxin system is required for the stable inheritance of the plasmid pAD1 in its
native host Enterococcus faecalis. It codes for the toxin Fst and a small antisense RNA which inhibits
translation of toxin mRNA, and it is the only known antisense regulated toxin-antitoxin system in Gram-
positive bacteria. This study presents the structure of the par toxin Fst, the first atomic resolution structure of
a component of an antisense regulated toxin-antitoxin system. The mode of membrane binding was
determined by relaxation enhancements in a paramagnetic environment and molecular dynamics simulation.
Fst forms a membrane-binding R-helix in the N-terminal part and contains an intrinsically disordered region
near the C-terminus. It binds in a transmembrane orientation with the C-terminus likely pointing toward the
cytosol. Membrane-bound, R-helical peptides are frequently found in higher organisms as components of the
innate immune system. Despite similarities to these antimicrobial peptides, Fst shows neither hemolytic nor
antimicrobialactivitywhenappliedexternallytoaseriesofbacteria,fungalcells,anderythrocytes.Moreover,
its charge distribution, orientation in the membrane, and structure distinguish it from antimicrobial peptides.
Plasmids are extrachromosomal genetic entities carrying addi-
tionalinformationforthehostorganism,andtheyrelymainlyon
the host machinery to be replicated. While the information
encoded on a plasmid can be beneficial to the cell under various
stress situations (e.g., exposure to antibiotics or heavy metals),
plasmids also harbor a nutritional burden for bacteria under
normal growth conditions. If the spread of the plasmid to
daughter cells was only a random process, low copy number
plasmidswouldgetlostfrombacterialcellswithinashortnumber
of generations. Plasmidic toxin-antitoxin (TA)
1 systems (also
knownaspostsegregationalkillingorplasmidaddictionsystems)
contribute to the stability of these mobile genetic elements in the
growinghostbacterialpopulation by killing daughter cellswhich
have not inherited a plasmid copy during cell division (1-3). TA
systems consist ofa stabletoxin andan unstable antitoxin, which
arebothproducedcontinuously.Iftheplasmidislost,thepoolof
short-lived antitoxin is soon degraded due to the lack of de novo
synthesis. The more stable toxin survives and thus kills plasmid-
free cells. Besides being an integral component of various
plasmids, TA systems were also found on bacterial chromo-
somes (4, 5). While the function on plasmids is pretty clear, there
is still no consensus about the function of chromosomal TAs.
Current hypotheses range from growth regulation or even
programmed cell death during stress conditions (e.g., starvation,
high temperatures,oxidative stress, or exposure to antibiotics) to
genomic junk (6-8).
Two typesofTAsystemsareknown: Type Isystemsconsist of
ashort(<60aminoacid)toxinandasmallantisenseRNAacting
as the antitoxin, which prohibits the translation of toxin
mRNA (9, 10). To exert its toxic function once the TA gene is
lost or downregulated, the antisense RNA has to be less stable
thanthetoxin-encodingmRNA.IntypeIIsystemsboththetoxin
and antitoxin are small (∼70-135 residues) homodimeric pro-
teins(1,5).Astabletoxinandashort-livedantitoxinformashort
operon whose transcription is autoregulated. The antitoxins
contain intrinsically unstructured regions, which can be readily
cleaved by proteases (Lon or Clp) (11). Much more information,
especially as far as their structures is concerned, is currently
available for type II toxin-antitoxin systems. Nine families of
type II TA systems have been found so far (CcdAB, RelBE,
MazEF, ParDE, phd/doc, VapBC, hipBA, HigBA, and epsilon/
zeta/omega)(3,8).Avarietyofstructuraldataisavailableforfree
toxin or antitoxins (CcdB (12, 13), Kid (14), MazE (15),
CcdA (16), ParD (17), VapC (18), omega (19), RelB (20),
RelE (21)), a complex of a toxin with its target (CcdB-
GyrA14) (22), toxin bound to antitoxin (MazE/MazF (23),
RelB/RelE (24), YefM/YoeB (25), ParD/ParE (26), MqsR/
MqsA (27), epsilon/zeta (28), PezA/PezT-DNA (29)), a DNA-
bound antitoxin (CcdA-DNA) (16), and even a ternary toxin-
antitoxin-DNAcomplex(FitA/FitB-DNA) (30).Neithersequences
nor folds are conserved among toxins or antitoxins, and there is
also great variability of combinations of toxin and antitoxin folds.
For example, while the toxins CcdB and MazF share a similar
fold (13, 23), their corresponding antitoxins CcdA (16)a n d
MazE (15) show completely unrelated structures. In contrast to type
II TA systems, there has so far been no report on the structure of a
type I toxin-antitoxin system component. Type I TA systems have
been found on plasmids and chromosomes (10). The first type I
†Financial support by the Austrian Science Foundation (Fonds zur
F€ orderung der wissenschaftlichen Forschung, FWF) under project
number 20020 to K.Z. and through the “Doktoratskolleg Molecular
Enzymology” is gratefully acknowledged. C.G. thanks the Austrian
Academy of Sciences (€ OAW) for a DOC fellowship.
*Corresponding author. E-mail: klaus.zangger@uni-graz.at.
Tel: þþ43 316 380-8673. Fax: þþ43 316 380-9840.
1Abbreviations: DPC, dodecylphosphocholine; Fst, faecalis plasmid
stabilization toxin; Fst1-27, N-terminal 27 residues of Fst; Gd(DTPA-
BMA),gadoliniumdiethylenetriaminepentaaceticacidbismethylamide;
MD, molecular dynamics simulations; NOESY, nuclear Overhauser
effect spectroscopy; POPC, 1-palmitoyl-2-oleoylphosphatidylcholine;
PRE,paramagneticrelaxationenhancement;RMSF,root-mean-square
fluctuations; TA, toxin-antitoxin; TOCSY, total correlation spectros-
copy; TPC, tetradecylphosphocholine.6568 Biochemistry, Vol. 49, No. 31, 2010 G€ obl et al.
systems found werethe Hok/Sok pairof plasmid R1(31) andthe
par locus of plasmid pAD1 (32). Homologues of Hok/Sok were
also found on the chromosomes of Escherichia coli and other
bacteria (33, 34). Other chromosomal TA systems include the ldr
(long direct repeat) sequences (35), the tisAB system (36), the
OhsC/ShoB pair (37, 38) (all in E. coli), and the TxpA/RatA
system (39)o fBacillus subtilis. Although comparably few type I
TA systems are known, there might be a much larger number
which is just not yet being recognized by current protocols of
genome searches as recently suggested (40). In all type I systems
the toxins are small hydrophobic peptides. For none of them is
the target known, but they seem to have some effect on bacterial
membranes (10). Here we present the structure of the toxin Fst
(faecalis plasmid stabilization toxin) (41)o ft h epar addiction
module of the plasmid pAD1 of Enterococcus faecalis, together
with its mode of interaction with membrane-mimetics. The par
toxin-antitoxin system, which was studied extensively by Wea-
ver et al. (32, 40-46), is the only one known in a Gram-positive
bacterium. The par locus on pAD1 codes for two small
RNAs, called RNA I (coding for the toxin) and RNA II
(the antisense RNA) which are convergently transcribed in
opposite directions across a pair of direct repeats toward a
bidirectional terminator (42). RNA I and RNA II form a
complex through various complementary interactions including
ones in the translation initiationregionfor the Fst toxin. The par
addiction system was found to have several homologues located
bothonplasmids andon chromosomesofGram-positive bacter-
ia (40). Translation of the toxin Fst m-RNA is inhibited through
binding of a small antisense RNA. Translated Fst peptide was
showntoaffectcellmembraneintegrityand caused defectsincell
division and chromosome segregation (46). Generally, atomic
resolution structure determinations of small membrane-bound
polypeptides are not possible by X-ray crystallography but can
becarried out byNMR spectroscopy ifthe system under study is
below the NMR size limit to prevent excessive line broadening.
Thus, small membrane-mimetic systems (typically micelles) have
to be used (47-49). Typically, the zwitterionic dodecylpho-
sphocholine (DPC) is employed (47, 48), since it structurally
resembles the components of major eukaryotic biological mem-
branes. It can well preserve the 3D structure of bound peptides
and proteins (50) as well as the catalytic activity of membrane-
bound enzymes (51, 52). Here we present the structure and mode
ofmembranebindingofthetoxinFstboundtoDPCmicelles,the
first atomic resolution structure of a type I TA system compo-
nent. Fst forms a transmembrane helix within the first ∼26
residues and contains a highly charged intrinsically unstructured
C-terminus which sticks into the cytosol.
EXPERIMENTAL PROCEDURES
Materials. Fst (MKDLMSLVIAPIFVGLVLEMISRVLD-
EEDDSRK) and Fst1-27 (MKDLMSLVIAPIFVGLVLEMIS-
RVLDE) were synthesized by FMOC-based solid-phase peptide
synthesis and purchased from Peptide Specialty Laboratories
GmbH (Heidelberg, Germany). Unlabeled and 98% deuterated
dodecylphosphocholines (DPC) as well as tetradecylphospho-
choline (TPC) were obtained from Anatrace Inc. (Maumee, OH)
atapurityhigherthan97%.Gd(DTPA-BMA)waspurifiedfrom
Omniscan (Nycomed, Oslo, Norway), a commercially available
MRI contrast agent, as described (53). All other chemicals were
purchased from Sigma-Aldrich (St. Louis, MO) in the highest
purity available.
NMRSpectroscopy. About1mgofpeptidewasdissolvedin
600 μL of a 100 mM DPC-d38 solution, buffered by 50 mM KPi,
pH 5.0, containing 0.02% NaN3 and 10% (v/v) D2O. All NMR
spectra were acquired on a Varian Unity INOVA 600 MHz
NMR spectrometer except the diffusion measurements which
were carried out on a Bruker Avance DRX 500 MHz NMR
spectrometer, both equipped with HCN triple-resonance probes
and z-axis gradients. Chemical shifts were referenced relative to
internal H2O. The H2O signal chemical shift was obtained
accordingtoδ(H2O) =7.83-T/96.9ppm(54).Two-dimensional
TOCSY spectra were acquired using different temperatures and
mixing times (293 K/50 ms, 303 K/50 ms, 308 K/50 ms, 323 K/
50 ms, and 308 K/30 ms, respectively). Two-dimensional NOESY
spectra were acquired at the same temperatures and a mixing
time of 150 ms. All spectra were processed using the programs
nmrPipe (55) and TopSpin 2.1 (Bruker). Data analysis was done
in NMRView 8.0.a22 (56). Self-diffusion coefficients were mea-
sured at 301 K by acquiring a series of nine pulsed-gradient
stimulated echo spectra with variation of gradient strengths from
10% to 90% of maximum power (maximum ∼50 G/cm). Signals
of interest were least-squares fitted to the equation
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where I and I0 correspond to the measured signal intensities at
gradient strengths G and 0, τ2 is the delay between the first and
second 90 pulse (1.05 ms) and τ1the delay between the second and
third 90 pulse (150 ms), T1 and T2 are the longitudinal and trans-
verse relaxation rates, γ is the gyromagnetic ratio, δ is the length of
the gradient (2 ms), Δ is the duration between the two gradients
(151ms),andDistheself-diffusioncoefficient.Duetouncertainties
ofsomeparametersinvolvedintheconstantsofeq1,asforexample
the exact gradient strengths, all parameters were combined into the
instrument-dependent constants “a”a n d“ b” according to
lnðIÞ¼a-bDG2 ð2Þ
and were obtained through calibration on an external water sample
as described elsewhere (47). The experimental data gave linear fits
with correlation coefficients typically above 0.99, proving the
linearity up to 90% gradient strength. Proton T1 relaxation times
wereobtainedfromaseriesof2DTOCSYspectrawithasaturation
recovery sequence at the beginning and using excitation sculpting
solvent suppression before acquisition. Eight 2D data sets were
acquired with recovery delays of 100, 200, 500, 700, 1000, 1500,
2000,and3000msand32scansforeachofthe512increments.Due
to the saturation period at the start of the sequence the interscan
delay could be reduced to 0.2 s (57). Longitudinal relaxation times
T1 were obtained by fitting the signal intensities to the equation
I ¼ I0ð1-e-t=T1Þð 3Þ
where I is the experimental signal intensity at time t, I0 the intensity
at time 0. and T1 the longitudinal relaxation time. T1 values are
calculated using the built-in Levenberg-Marquardt fitting algo-
rithm in NMRView. PRE values were obtained by determination
of the slopes of relaxation rates versus the concentration of added
paramagnetic compound.
CD Spectroscopy. Far-UV CD experiments were recorded
on a J-715 spectrapolarimeter with a PTC343 peltier unit (Jasco,
Tokyo, Japan). Spectra were acquired at room temperature with
a response time of 1 s and a step resolution of 0.2 nm. Five scans
wereaveragedtoobtainsmoothspectra,andthebackgroundwasArticle Biochemistry, Vol. 49, No. 31, 2010 6569
corrected. The CD spectra were obtained on 100 μM Fst and
133 μMF s t 1-27. A buffer consisting of 100 mM TPC, 50 mM
KPi, pH 5.0, and 0.02% NaN3 was used.
Structure Determination. Peak intensities of manually as-
signed NOESY spectra were translated by the program
NMRView into distance restraints using the built-in median
method.Themedianintensitywassettoadistanceof2.7A ˚ inthe
NOESY spectra of both Fst and Fst1-27. Additionally, φ and ψ
angle restraints were obtained with the PREDITOR web ser-
ver (58) using chemical shifts of amide and R-protons. A total of
279 NOEs and 25 φ-angle and 24 ψ-angle restraints were used as
experimental input for the full simulated annealing structure
calculation method using the CNS software package (59).
Visualization of structures was carried out by the programs
Pymol (60) and Molmol (61).
Hemolytic Activity. Human erythrocytes (donated by S. K.;
healthy 29-year-old female) were used to explore the hemolytic
activityofthepeptideaspreviouslydescribed(62).Thebloodwas
centrifuged and washed four times with 0.9% NaCl solution to
dispose of the plasma. Fst and Fst1-27 dissolved in PBS þ 5%
DMSO (pH 7.4) were added to erythrocytes (1   10
8 cells/mL in
0.9% NaCl). The suspensions were incubated for 2 h at 37 C.
The samples were centrifuged, and the optical density of the
supernatant was measured at 451 nm to determine the extent of
hemolysis. Hypotonically lyzed erythrocytes were used as a
standard for 100% hemolysis. The experiment was repeated
three times including positive and negative controls.
AntimicrobialActivity. The antimicrobial activity was tested
with an inhibition zone assay on agar plates according to Hult-
mark et al. (63). The peptide was serially diluted in 100 mM TPC
solution, containing 50 mM potassium phosphate at pH 5.5.
Inhibition zones were measured from wells filled with 5 μLo f
peptide solutions and in parallel from sterile paper disks (Sigma-
Aldrich) loaded with 20 μL of peptide solution. Each experiment
was repeated three times, and disk diameters were considered in
the calculations. Bacterial and fungal strains used in this assay
were the Gram-negative E. coli (BL 21), the Gram-positive strains
B. subtilis (DSM 1089) and Enterococcus caccae (DSM 19114),
and the fungal strains Candida parapsilosis (NBCC 0707) and
Saccharomyces cerevisiae (BCY 1020). E. caccae is phylogeneti-
cally closely related to the Fst producing E, faecalis (64)b u t
less pathogenic. Bacteria and fungi were grown to an OD600 of
0.7 in Luria-Bertani broth (LB; Sigma-Aldrich) and universal
medium (YM), respectively. In midlogarithmic phase bacteria
were diluted in LB medium and approximately 2   10
5 colony
forming units (CFU) plated on Petri dishes with LB þ 1.5%
agar (Sigma-Aldrich). Fungal cells were diluted in YM and
plated on Petri dishes with YM þ 1.5% agar.
Molecular Dynamics Simulations. The simulation system
was constructed from an equilibrated POPC bilayer (65) consist-
ing of 200 1-palmitoyl-2-oleoylphosphatidylcholine (POPC) mo-
leculesand35watermoleculesperlipid.Twofull-lengthFsttoxin
peptides were inserted using g_membed (66). Thereby, two
peptides were sequentially first overlaid with the preequilibrated
membrane at the largest possible distance from one another and
then scaled by 0.1 in the membrane plane. Still overlapping lipid
(cutoff radius 0.22 nm) and water molecules were removed.
The peptides were subsequently expanded to their original size
while pushing on water and lipid molecules. The system was
electroneutralized by adding four K
þ ions. Further K
þ and Cl
-
ions were added to obtain a 100 mM concentration. The system
was equilibrated for 5 ns while restraining the position of the Fst
peptides with 1000 kJ/mol. Subsequently, 50 ns production runs
were carried out. Berger lipids (67), converted into the format of
the OPLS all-atom force field (40), were used to describe the
POPC molecules. The OPLS all-atom force field was applied for
the Fst peptide. The SPC (68) water model was used. The
simulation was performed using the Gromacs 4.0.7 MD pack-
age (69, 70) using an integration time step of 2 fs and a neighbor
search list updated at every 10th step. The temperature was
maintained at 310 K using the velocity rescale (v-rescale) algo-
rithm (71) applying a coupling time of 0.1 ps, independently
coupling water plus ions and lipids plus Fst peptides to an
external bath. Pressure was maintained at 1 bar both in the
membrane plane and in the membrane normal using the semi-
isotropic Berendsen pressure coupling scheme (72) with a time
constantof4ps.BondlengthswereconstrainedusingtheLINCS
method (73). A cutoff of 1.0 nm was applied for vdW interac-
tions. Long-range electrostatic interactions were calculated ap-
plying the particle mesh Ewald method (74) using a cutoff of 1.0
nm, and the reciprocal space interactions were evaluated on a
0.14 nm grid using fourth-order B-splines. Periodic boundary
conditions were applied in all dimensions.
RESULTS AND DISCUSSION
Fst was insoluble in water but can be easily solubilized by
adding membrane mimetics. Well-resolved 1D NMR spectra
could be acquired even at relatively low DPC concentrations of
50 mM. No significant changes in the NMR spectra were
observed beyond 100 mM DPC-d38. Unlabeled peptides in
micelles can be structurally characterized typically up to ∼30
residues by solution NMR. The spectra of Fst showed a few very
strong and slowly relaxing peaks (based on their narrow line
width) while most signals are very weak and broad. The strong
signalscouldbefullysequentiallyassignedusing2DTOCSYand
NOESYspectra.Theyallbelong tothelast7 C-terminalresidues
and are characterized by chemical shifts close to random coil
values,and they show only trivial NOEs.Thus the C-terminus of
Fst is intrinsically unstructured. Only a few of the other residues
could be assigned. Besides being much broader and therefore
weaker, these amino acids have chemical shifts closer to values
observed in R-helical peptide and protein regions (75). To enable
theassignmentandstructuredeterminationalsoofthestructured
partofFst,ashorterversionofthepeptidewassynthesizedwhich
consists of the 27 N-terminal residues (Fst1-27). Fst1-27 is also
insoluble in water but can be easily dissolved in 100 mM DPC-
d38. The TOCSY and NOESY spectra of Fst1-27 show a much
more uniform distribution of signal intensities and line widths.
The chemical shifts of the signals stemming from the N-terminal
27residuesofFstareverysimilartothoseofFst1-27(seeFigure1).
Therefore, the structure and probably also mode of membrane
binding of Fst1-27 represent quite well the one for these residues
infull-lengthFst.Additionally,CDspectraofFstandFst1-27are
verysimilar(seeFigure2).BothshowtypicalR-helicalsecondary
structure formation in phosphocholine micelles with minima at
207 and 222 nm. The molar ellipticity per residue is higher for
Fst1-27 as expected for an overall better structured peptide
(Figure 2).Toenablethe complete assignment ofFst1-27,s e v e r a l
two-dimensional TOCSY and NOESY spectra at different
temperatures between 293 and 325 K had to be acquired to
resolve overlapping signals. All but the very first N-terminal
residuecouldbeassigned,andthechemicalshiftsaredepositedin
the BMRB database under accession number 16769. No NOEs6570 Biochemistry, Vol. 49, No. 31, 2010 G€ obl et al.
between the last 6 C-terminal residues of Fst with the first
27 residues were found, and all NOEs within the first 27 residues
of Fst were also found in Fst1-27. Therefore, we combined the
NOEsofFst1-27 with theonesfoundforthelast6residuesofFst
for the structure calculation of full-length Fst. It should be noted
that due to the different dynamical behavior between the first
27 and last 6 residues the translation of NOEs into distances is
probably not uniform along the peptide chain. However, since
only trivial NOEs were found in the C-terminal region and to
indicate the increased flexibility in this part of the peptide, we
included these additional NOEs from full-length Fst into the
structure calculation. The NOE connectivity pattern of Fst
(Figure 3) shows typical R-helix NOEs (dRN(i,i þ 4), dRN(i,i þ 3),
and dRβ(i,i þ 3)) (75) for residues ∼4-27. For the structure
calculation a total of 279 NOEs from both Fst and Fst1-27 were
used together with 49 φ and ψ angle restraints derived from
chemical shifts using the PREDITOR webserver. A total of 100
structures were calculated in CNS 1.1, and the 20 lowest energies
which gave no NOE and dihedral angle violations are shown in
Figure 4 and are deposited in the PDB database under accession
number 2kv5 (Table 1). Fst forms an R-helical structure between
FIGURE 1: Overlayofthefingerprintregionof2DTOCSYspectraofFst(red)andFst1-27(black)at301K.Correlationsbetweenamideprotons
andR-protonsareindicatedbytheresiduenumbers.Cross-peaksbetweenNHandother(non-R) protonsareindicatedbythepositionintheside
chain.
Table 1: Structural Statistics of Fst in 100 mM DPC Micelles
restraints
NOE restraints
intraresidue NOEs 140
interresidue NOEs (i, iþ1) 73
medium-range NOEs (i, iþ2,3,4) 66
total NOEs 279
angle restraints
φ angles (2-26) 25
ψ angle (2-25) 24
energies (kcal/mol)
total 56.4 ( 2.4
bond 1.6 ( 0.4
angle 23.7 ( 0.8
improper 1.4 ( 0.2
van der Waals 18.6 ( 1.5
NOE 10.7 ( 0.7
dihedral 0.27 ( 0.03
statistics (5-25)
rmsd for backbone atoms 0.41
rmsd for all atoms 1.27
number of NOE violations >0.5 A ˚ 0
number of dihedral angle violations >5 0
Ramachandran plot details
residues in most favored regions 91.1%
residues in additionally allowed regions 8.9%
residues in generously allowed regions 0.0%
residues in disallowed regions 0.0%
statistics (1-33)
rmsd for backbone atoms 2.03
rmsd for all atoms 3.63
number of NOE violations >0.5 A ˚ 0
number of dihedral angle violations >5 0
Ramachandran plot details
residues in most favored regions 75.7%
residues in additionally allowed regions 22.9%
residues in generously allowed regions 1.0%
residues in disallowed regions 0.3%
FIGURE 2: CD spectra of Fst (filled circles) and Fst1-27 (empty
circles)in100 mMTPCsolutionshowingthe meanresidueellipticity
(mre) per residue versus the wavelength. The reduced mean residual
ellipticity of Fst is a result of the intrinsically disordered C-terminus.Article Biochemistry, Vol. 49, No. 31, 2010 6571
amino acids 5and26.Aproline known as apotential destabilizer
of secondary structure is found at position 11. In Fst, the R-helix
is well-defined at the proline residue, showing clear and well-
resolved NOEs to amino acids 7, 8, 10, 12, and 14. A glycine
residue at position 15 gives NOEs to amino acids 12, 14, 16, and
17, but the number of NOE connectivities of glycines is generally
low as a result of the lack of side chain atoms. Although still
R-helical, small distortions in the final structures around glycine
15 result in a slightly bent R-helix. As expected based on the
narrow line widths and low numbers of (only trivial) NOEs
found, the last 7 C-terminal residues are completely disordered.
Besidesthestructure,knowingtheorientationandlocationinside
a membrane are also important to understand the function of
membrane-bound peptides and proteins. The positioning of a
peptide in a small membrane-mimetic can be determined using
relaxation enhancements induced by the inert and soluble para-
magnetic probe gadolinium diethylenetriaminepentaacetic acid
bismethylamide (Gd(DTPA-BMA)) (53, 76-78). Using this
complex the orientation of the peptide in the micelle can be
studied without chemical modification of the peptide or micelle.
Since the orientation of Fst and Fst1-27 in the micelle might be
differentdue tothechangedchargeofthe C-terminus,wedidnot
attempt to determine the orientation of Fst1-27 but only full-
length Fst. Paramagnetic relaxation enhancements (PREs) were
acquired by addition of Gd(DTPA-BMA) to concentrations of
0.98 and 1.95 mM. Due to extensive line broadening of most
residues within the structured region of Fst, PREs could only be
determined for amino acids 2, 14, 17, 29, and 31-33. The PRE
values(seeFigure5)arehighneartheterminiandmuchlowerfor
residues 14 and 17 and thus indicate that Fst penetrates directly
through the micelle. It obviously forms a transmembrane helix
with the first ∼2 and last ∼7 residues sticking out of the
membrane. Side chain protons 2.Hε3 and 32.Hε show higher
values than backbone protons.These polar lysine(residue 2) and
arginine (residue 32) side chains obviously snorkel into the
aqueous solution surrounding the micelle. Further insight into
themodeofmembrane-bindingofFstwasobtainedbymolecular
dynamicssimulations.SimulationoftwoFstpeptides,insertedin
a preequilibrated membrane by overlapping the hydrophobic
regions of the POPC membrane and the Fst peptide, was carried
out for 50 ns. The use of two peptides allows for duplication of
conformational phase space sampling and for an internal con-
sistency control. Both peptide molecules were found to behave
similarly. In Figure 6 a representative snapshot of the simulation
is shown. The polar headgroup region of the membrane is
FIGURE 3: Sequence plot of Fst and Fst1-27. The strengths of the
NOEs are indicated by the thicknesses of the bars.
FIGURE 4: Least-squares superposition of the 20 lowest energy structures of Fst showing all atoms (a) or the backbone only (b). The backbone
atoms of residues 5-25 were used for the fitting.6572 Biochemistry, Vol. 49, No. 31, 2010 G€ obl et al.
highlighted by the blue spheres of the phosphate atoms. Both
peptides show a similar conformation with the hydrophobic part
well within the hydrophobic region of the membrane. At the
N-terminusthepeptidesreachtheedgeofthemembrane,whileat
the C-terminus, in perfect accordance with our experimental
results, the polar residues are water exposed. Glu19 and Arg23
form a salt bridge and/or reach to the polar headgroup region of
the membrane. The mobility of the individual residues is shown
as root-mean-square fluctuations (RMSF) in Figure 7, averaged
over both peptides. Residues within the membrane show a low
level of fluctuation, while especially at the C-terminus, beginning
with residue Asp26, the mobility of the residues strongly
increases. An analysis of the secondary structure (79)i ss h o w n
in Figure 8. The transmembrane part, including residues As-
p3-Asp26formsastablehelicalstructure,whichcanbeobserved
throughout the 50 ns time window in both peptides. Consistent
with the NMR data, due to increased dynamics, no stable
secondary structure is observed at the C-terminal region.
The binding of well-immersed peptides of comparable size of
Fst1-27 to micelles results in hydrodynamic radii not remarkably
different from pure micelles (47). A radius of 23.4 ( 2.0 A ˚ was
obtained for Fst1-27 bound to DPC micelles using self-diffusion
NMR experiments, whereas 23.3 ( 1.4 A ˚ was found previously
for a pure DPC solution (47). An unusually large proportion of
charged residues is found near the C-terminus. A strongly
negatively charged stretch (D26-D30) is found right where the
peptide leaves the membrane. Since the outside of Gram-positive
membranes is negatively charged, Fst likely binds to the cell
membrane with the C-terminus pointing into the cytosol. This
orientation(outsidetoinside)isalsothestronglypreferredmodel
obtained with the transmembrane helix tool TMpred (80).
All type I TA system toxins are small hydrophobic peptides
andatleastFstismainlyR-helical.Overexpressionofseveraltype
I toxins has been shown to lead to membrane depolarization or
disruption. Based on these observations it has been speculated
that type I toxins might act extracellularly, similar to antimicro-
bial peptides (9). Antimicrobial peptides occur in a wide variety
of hosts, including bacteria (81), and show a strong activity
FIGURE 5: Longitudinal(R1)paramagneticrelaxationenhancements
(PREs) of Fst obtained by adding Gd(DTPA-BMA). Only values of
well-resolved peaks with correlation coefficients of least-squares fits
higher than 0.98 were used. A low PRE is indicative of a larger
distance from the micelle surface.
FIGURE 6: Representative structures of Fst of a 50 ns MD simulation run. The peptide is shown as a color-coded ribbon (red = negatively
charged, blue = positively charged, green = polar, including glycine, and white = unpolar). The phosphate headgroups are indicated by blue
spheres.
FIGURE 7: Residueroot-mean-squarefluctuation:averageRMSFof
each residue, averaged over the entire simulation, and both peptides
are shown together with the standard deviation.Article Biochemistry, Vol. 49, No. 31, 2010 6573
against microorganisms (82, 83). They are part of the innate
immune system that protects the host in an unspecific manner.
Interestingly, some of the first bacterial antimicrobial peptides
were found in Enterococci (84) and even the pAD1 plasmid of E.
faecalis (85). The host organism itself is immune through the
coexpression of immunity proteins (81). According to the com-
monly accepted Shai-Matsuzaki-Huang model, antimicrobial
peptides bind to the membrane surface and, after reaching a
critical concentration, penetrate the membrane and lyze it
through pore formation (86-89). This leads to collapse of the
transmembrane electrochemical gradient and, finally, to cell
death (88, 89). To examine any potential antibiotic properties,
we investigated the hemolytic and antimicrobial activity of Fst.
Neither Fst nor Fst1-27 lyzed red blood cells. Both peptides were
not able to lyze the membranes of erythrocytes up to a concen-
tration of 100 μMpeptide.Also,bothpeptidesdid notinhibitthe
growth of bacterial or fungal strains when tested in inhibition
zone assays. The toxin and its truncated form were assayed
against the yeast strains C. parapsilosis and S. cerevisiae against
which they did not show any toxic activity. The same negative
result was obtained for the Gram-negative E. coli and the Gram-
positive B. subtilis. The growth of the species E. caccae which is
closely related to the Fst producing E. faecalis (64)w a sa l s on o t
inhibited by any of the two peptides. This is consistent with
results of a study by Weaver et al. (46), where Fst was added to
liquidculturesofE.faecaliswithoutshowinganyinfluenceonthe
growth of the bacterium. Although they found a negative effect
on membrane integrity when overexpressing Fst in E. faecalis
cells, the mechanism of action of Fst is obviously different from
antimicrobial peptides. Despite some apparent similarities be-
tween toxins of type I TA systems and antimicrobial peptides,
onehastokeepinmindthatthebiologicalrolesareverydifferent.
Antimicrobialpeptidesserveasafirstdefensemechanismagainst
a broadrange of microbes andare produced byorganisms which
themselves are not affected by them. Type I toxins, on the other
hand, ensure the maintenance of a plasmid in a bacterial
population by killing cells that did not inherit these genes. Thus
theyhavetoexerttheirtoxiceffectrightinthecellwhichproduces
them, and it would make no sense to secrete them into the
environmentandalsokillothercellswhichharbortheTAcoding
plasmid. In contrast to antimicrobial peptides, Fst works suppo-
sedly on a specific target inside the cell. While antimicrobial
peptides are usually aligned parallel to the membrane surface
prior to pore formation, Fst is in a transmembrane orientation.
In addition, antimicrobial peptides are usually completely im-
mersed in the membrane (62), and Fst contains a C-terminus
which sticks into the cytosol. Weaver et al. also found that the
primary function of Fst is likely an inhibition of macromolecule
synthesis in the cell (46). While a perturbation in membrane
integrity and topology was observed, the main effects of Fst are
related to chromosome segregation and cell division. We believe
that Fst is located in the membrane to facilitate interactions with
a specific membrane-bound target rather than being directed
againstthemembraneitself.Insertionintothemembranereduces
the problem of finding its target from a three-dimensional (freely
soluble) to a two-dimensional (gliding in the membrane) search.
The C-terminus might become structured upon binding to its
specific target. Intrinsically disordered proteins (90)o rd o m a i n s
have a reduced energy barrier when binding to their targets as
they can more readily adapt to the structure in the bound state
without the need to unfold beforehand.
Inconclusion,thestructureandmodeofmembranebindingof
Fst, the first atomic resolution structure of a type I tox-
in-antitoxin system component, are presented. Fst binds to
membranes via the insertion of an R-helix between residues
∼4-26 and contains an intrinsically disordered stretch near the
C-terminus. The N- and C-termini stick out of the membrane,
likelywiththehighlychargedC-terminalregionpointingintothe
cytosol. The transmembrane orientation and charge distribution
as well as the unstructured, protruding C-terminus distinguish it
from antimicrobial peptides. It shows no hemolytic or toxic
effectswhenFstwasappliedexternallytoaseriesofmicrobesand
is obviously directed against a specific membrane-bound target
inside E. faecalis cells.
FIGURE 8: Time evolution of the secondary structure of the two Fst toxin peptides.6574 Biochemistry, Vol. 49, No. 31, 2010 G€ obl et al.
REFERENCES
1. Buts, L., Lah, J., Dao-Thi, M. H., Wyns, L., and Loris, R. (2005)
Toxin-antitoxin modules as bacterial metabolic stress managers.
Trends Biochem. Sci. 30, 672–679.
2. Gerdes, K.,Christensen, S.K.,andLobner-Olesen, A. (2005) Prokar-
yotic toxin-antitoxin stress response loci. Nat. Rev. Microbiol. 3,
371–382.
3. Pandey, D. P., and Gerdes, K. (2005) Toxin-antitoxin loci are highly
abundant in free-living but lost from host-associated prokaryotes.
Nucleic Acids Res. 33, 966–976.
4. Engelberg-Kulka, H., and Glaser, G. (1999) Addiction modules and
programmedcelldeathandantideathinbacterialcultures.Annu.Rev.
Microbiol. 53, 43–70.
5. Hayes, F. (2003) Toxins-antitoxins: plasmid maintenance, pro-
grammed cell death, and cell cycle arrest. Science 301, 1496–1499.
6. Christensen, S. K., Mikkelsen, M., Pedersen, K., and Gerdes, K.
(2001) RelE, a global inhibitor of translation, is activated during
nutritional stress. Proc. Natl. Acad. Sci. U.S.A. 98, 14328–14333.
7. Magnuson, R. D. (2007) Hypothetical functions of toxin-antitoxin
systems. J. Bacteriol. 189, 6089–6092.
8. Van Melderen, L., and Saavedra De Bast, M. (2009) Bacterial toxin-
antitoxin systems: more than selfish entities? PLoS Genet. 5,
e1000437.
9. Fozo, E. M., Hemm, M. R., and Storz, G. (2008) Small toxic proteins
and the antisense RNAs that repress them. Microbiol. Mol. Biol. Rev.
72, 579–589.
10. Gerdes,K.,andWagner,E.G.H.(2007)RNAantitoxins.Curr.Opin.
Microbiol. 10, 117–124.
11. Van Melderen, L., Thi, M. H., Lecchi, P., Gottesman, S., Couturier,
M., and Maurizi, M. R. (1996) ATP-dependent degradation of CcdA
by Lon protease. Effects of secondary structure and heterologous
subunit interactions. J. Biol. Chem. 271, 27730–27738.
12. De Jonge, N., Hohlweg, W., Garcia-Pino, A., Respondek, M., Buts,
L.,Haesaerts,S.,Lah,J.,Zangger,K.,andLoris,R.(2010)Structural
and thermodynamic characterization of Vibrio fischeri CcdB. J. Biol.
Chem. 285, 5606–5613.
13. Loris, R., Dao-Thi, M. H., Bahassi, E. M., Van Melderen, L.,
Poortmans, F., Liddington, R., Couturier, M., and Wyns, L. (1999)
Crystal structure of CcdB, a topoisomerase poison from E. coli. J.
Mol. Biol. 285, 1667–1677.
14. Hargreaves,D.,Santos-Sierra,S.,Giraldo,R.,Sabariegos-Jareno,R.,
de la Cueva-Mendez, G., Boelens, R., Diaz-Orejas, R., and Rafferty,
J. B. (2002) Structural and functional analysis of the kid toxin protein
from E. coli plasmid R1. Structure 10, 1425–1433.
15. Loris, R., Marianovsky, I., Lah, J., Laeremans, T., Engelberg-Kulka,
H., Glaser, G., Muyldermans, S., and Wyns, L. (2003) Crystal
structure of the intrinsically flexible addiction antidote MazE. J. Biol.
Chem. 278, 28252–28257.
16. Madl, T., Van Melderen, L., Mine, N., Respondek, M., Oberer, M.,
Keller, W., Khatai, L., and Zangger, K. (2006) Structural basis for
nucleic acid and toxin recognition of the bacterial antitoxin CcdA.
J. Mol. Biol. 364, 170–185.
17. Oberer, M., Zangger, K., Gruber, K., and Keller, W. (2007) The
solution structure of ParD, the antidote of the ParDE toxin antitoxin
module, provides the structural basis for DNA and toxin binding.
Protein Sci. 16, 1676–1688.
18. Richard, D. B., Joanna, L. M., Edward, N. B., and Vickery, L. A.
(2008)Crystal structure of PAE0151from Pyrobaculum aerophilum,a
PIN-domain (VapC) protein froma toxin-antitoxinoperon. Proteins:
Struct., Funct., Bioinf. 72, 510–518.
19. Murayama, K., Orth, P., de la Hoz, A. B., Alonso, J. C., and Saenger,
W. (2001) Crystal structure of [omega] transcriptional repressor
encoded by Streptococcus pyogenes plasmid pSM19035 at 1.5 A ˚
resolution. J. Mol. Biol. 314, 789–796.
20. Li, G.-Y., Zhang, Y., Inouye, M., and Ikura, M. (2008) Structural
mechanism of transcriptional autorepression of the Escherichia coli
RelB/RelE antitoxin/toxin module. J. Mol. Biol. 380, 107–119.
21. Neubauer, C., Gao, Y. G., Andersen, K. R., Dunham, C. M., Kelley,
A. C., Hentschel, J., Gerdes, K., Ramakrishnan, V., and Brodersen,
D. E. (2009)The structural basis for mRNA recognition and cleavage
by the ribosome-dependent endonuclease RelE. Cell 139, 1084–1095.
22. Dao-Thi, M. H., Van Melderen, L., De Genst, E., Afif, H., Buts, L.,
Wyns,L.,andLoris,R.(2005)Molecularbasisofgyrasepoisoningby
the addiction toxin CcdB. J. Mol. Biol. 348, 1091–1102.
23. Kamada, K., Hanaoka, F., and Burley, S. K. (2003) Crystal structure
of the MazE/MazF complex: molecular bases of antidote-toxin
recognition. Mol. Cell 11, 875–884.
24. Takagi,H.,Kakuta,Y.,Okada,T.,Yao,M.,Tanaka,I.,andKimura,
M. (2005) Crystal structure of archaeal toxin-antitoxin RelE-RelB
complexwithimplicationsfortoxinactivityandantitoxineffects.Nat.
Struct. Mol. Biol. 12, 327–331.
25. Kamada, K., and Hanaoka, F. (2005) Conformational change in the
catalytic site of the ribonuclease YoeB toxin by YefM antitoxin. Mol.
Cell 19, 497–509.
26. Dalton, K. M., and Crosson, S. A. (2010) Conserved mode of protein
recognition and binding in a ParD-ParE toxin-antitoxin complex,
Biochemistry (in press).
27. Brown, B. L., Grigoriu, S., Kim, Y., Arruda, J. M., Davenport, A.,
Wood, T. K., Peti, W., and Page, R. (2009) Three dimensional
structure of the MqsR:MqsA complex: a novel TA Pair comprised
of a toxin homologous to RelE and an antitoxin with unique proper-
ties. PLoS Pathog. 5, e1000706.
28. Meinhart, A., Alonso, J. C., Strater, N., and Saenger, W. (2003)
Crystal structure of the plasmid maintenance system epsilon/zeta:
functional mechanism of toxin zeta and inactivation by epsilon 2 zeta
2 complex formation. Proc. Natl. Acad. Sci. U.S.A. 100, 1661–1666.
29. Khoo, S. K., Loll, B., Chan, W. T., Shoeman, R. L., Ngoo, L., Yeo,
C. C., and Meinhart, A. (2007) Molecular and structural character-
ization of the PezAT chromosomal toxin-antitoxin system of the
human pathogen Streptococcus pneumoniae. J. Biol. Chem. 282,
19606–19618.
30. Mattison, K., Wilbur, J. S., So, M., and Brennan, R. G. (2006)
StructureofFitABfromNeisseriagonorrhoeaeboundtoDNAreveals
a tetramer of toxin-antitoxin heterodimers containing pin domains
and ribbon-helix-helix motifs. J. Biol. Chem. 281, 37942–37951.
31. Gerdes, K., Thisted, T., and Martinussen, J. (1990) Mechanism of
post-segregational killing by the hok/sok system of plasmid R1: sok
antisense RNA regulates formation of a hok mRNA species corre-
lated with killing of plasmid-free cells. Mol. Microbiol. 4, 1807–1818.
32. Weaver, K. E., and Tritle, D. J. (1994) Identification and character-
ization of an Enterococcus faecalis plasmid pAD1-encoded stability
determinant which produces two small rna molecules necessary for its
function. Plasmid 32, 168–181.
33. Faridani,O. R., Nikravesh, A., Pandey, D.P.,Gerdes,K.,andGood,
L. (2006) Competitive inhibition of natural antisense Sok-RNA
interactions activates Hok-mediated cell killing in Escherichia coli.
Nucleic Acids Res. 34, 5915–5922.
34. Pedersen, K., and Gerdes, K. (1999) Multiple hok genes on the
chromosome of Escherichia coli. Mol. Microbiol. 32, 1090–1102.
35. Kawano, M., Oshima, T., Kasai, H., and Mori, H. (2002) Molecular
characterization of long direct repeat (LDR) sequences expressing a
stable mRNA encoding for a 35-amino-acid cell-killing peptide and a
cis-encoded small antisense RNA in Escherichia coli. Mol. Microbiol.
45, 333–349.
36. Vogel, J., Argaman, L., Wagner, E. G., and Altuvia, S. (2004) The
small RNA IstR inhibits synthesis of an SOS-induced toxic peptide.
Curr. Biol. 14, 2271–2276.
37. Fozo, E. M., Kawano, M., Fontaine, F., Kaya, Y., Mendieta, K. S.,
Jones, K. L., Ocampo, A., Rudd, K. E., and Storz, G. (2008)
Repression of small toxic protein synthesis by the Sib and OhsC small
RNAs. Mol. Microbiol. 70, 1076–1093.
38. Kawano,M.,Reynolds,A.A.,Miranda-Rios,J.,andStorz,G.(2005)
Detection of 50- and 30-UTR-derived small RNAs and cis-encoded
antisense RNAs in Escherichia coli. Nucleic Acids Res. 33, 1040–1050.
39. Silvaggi, J. M., Perkins, J. B., and Losick, R. (2005) Small untrans-
lated RNA antitoxin in Bacillus subtilis. J. Bacteriol. 187, 6641–6650.
40. Weaver, K. E., Reddy, S. G., Brinkman, C. L., Patel, S., Bayles,
K. W., and Endres, J. L. (2009) Identification and characterization of
afamilyoftoxin-antitoxinsystemsrelatedtotheEnterococcusfaecalis
plasmid pAD1 par addiction module. Microbiology 155, 2930–2940.
41. Greenfield, T. J., Ehli, E., Kirshenmann, T., Franch, T., Gerdes, K.,
and Weaver, K. E. (2000) The antisense RNA of the par locus of
pAD1 regulates the expression of a 33-amino-acid toxic peptide by an
unusual mechanism. Mol. Microbiol. 37, 652–660.
42. Greenfield,T.J.,andWeaver,K.E.(2000)AntisenseRNAregulation
ofthepAD1parpost-segregationalkillingsystemrequiresinteraction
at the 50 and 30 ends of the RNAs. Mol. Microbiol. 37, 661–670.
43. Weaver, K. E. (2007) Emerging plasmid-encoded antisense RNA
regulated systems. Curr. Opin. Microbiol. 10, 110–116.
44. Weaver, K. E., Clewell, D. B., and An, F. (1993) Identification,
characterization, and nucleotide sequence of a region of Enterococcus
faecalis pheromone-responsive plasmid pAD1 capable of autono-
mous replication. J. Bacteriol. 175, 1900–1909.
45. Weaver, K. E., Walz, K. D., and Heine, M. S. (1998) Isolation of a
derivative of Escherichia coli-Enterococcus faecalis shuttle vector
pAM401 temperature sensitive for maintenance in E. faecalis and its
use in evaluating the mechanism of pAD1par-dependent plasmid
stabilization. Plasmid 40, 225–232.Article Biochemistry, Vol. 49, No. 31, 2010 6575
46. Weaver, K. E., Weaver, D. M., Wells, C. L., Waters, C. M., Gardner,
M. E., and Ehli, E. A. (2003) Enterococcus faecalis plasmid pAD1-
encoded Fst toxin affects membrane permeability and alters cellular
responses to lantibiotics. J. Bacteriol. 185, 2169–2177.
47. G€ obl, C., Dulle, M., Hohlweg, W., Grossauer, J., Falsone, S. F.,
Glatter,O.,andZangger,K.(2010)Influenceofphosphocholinealkyl
chain length on peptide-micelle interactions and micellar size and
shape. J. Phys. Chem. B 114, 4717–4724.
48. Kallick, D.A.,Tessmer,M.R., Watts,C.R.,andLi,C.Y.(1995)The
use of dodecylphosphocholine micelles in solution NMR. J. Magn.
Reson. B 109, 60–65.
49. Lauterwein, J., Boesch, C., Brown, L. R., and Wuethrich, K. (1979)
Physicochemical studies of the protein-lipid interactions in melittin-
containing micelles. Biochim. Biophys. Acta 556, 244–264.
50. Arora, A., Abildgaard, F., Bushweller, J.H.,and Tamm, L. K. (2001)
Structure of outer membrane protein A transmembrane domain by
NMR spectroscopy. Nat. Struct. Biol. 8, 334–338.
51. Czerski, L., and Sanders, C. R. (2000) Functionality of a membrane
protein in bicelles. Anal. Biochem. 284, 327–333.
52. Vinogradova, O., S€ onnichsen, F., and Sanders, C. R. (1998) On
choosingadetergentforsolutionNMRstudiesofmembraneproteins.
J. Biomol. NMR 11, 381–386.
53. Respondek, M., Madl, T., G€ obl, C., Golser, R., and Zangger, K.
(2007) Mapping the orientation of helices in micelle-bound pep-
tides by paramagnetic relaxation waves. J. Am. Chem. Soc. 129,
5228–5234.
54. Cavanagh, J., Fairbrother, W. J., Palmer, A. G., and Skelton, N. J.
(1996) Protein NMR Spectroscopy, Academic Press, San Diego, CA.
55. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and
Bax, A. (1995) NMRPipe: a multidimensional spectral processing
system based on UNIX pipes. J. Biomol. NMR 6, 277–293.
56. Johnson,B.A.,andBlevins,R.A.(1994)Acomputerprogramforthe
visualization and analysis of NMR data. J. Biomol. NMR 4, 603–614.
57. Madl, T., Bermel, W., and Zangger, K. (2009) Use of relaxation
enhancements in a paramagnetic environment for the structure
determination of proteins using NMR spectroscopy. Angew. Chem.,
Int. Ed. Engl. 48, 8259–8262.
58. Berjanskii, M. V., Neal, S., and Wishart, D. S. (2006) PREDITOR: a
web server for predicting protein torsion angle restraints. Nucleic
Acids Res. 34, W63–69.
59. Br€ unger,A.T., Adams,P.D.,Clore,G.M., DeLano,W.L.,Gros,P.,
Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M.,
Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren,
G.L.(1998)Crystallography&NMRsystem:anewsoftwaresuitefor
macromolecular structure determination. Acta Crystallogr., Sect. D:
Biol. Crystallogr. 54, 905–921.
60. DeLano, W. L. (2002) The PyMOL Molecular Graphics System,
DeLano Scientific, Palo Alto, CA.
61. Koradi, R., Billeter, M., and Wuthrich, K. (1996) MOLMOL: a
program for display and analysis of macromolecular structures.
J. Mol. Graphics 14, 51–55.
62. Kosol, S., and Zangger, K. (2010) Dynamics and orientation of a
cationic antimicrobial peptide in two membrane-mimetic systems.
J. Struct. Biol. 170, 172–179.
63. Hultmark, D., Engstrom, A., Bennich, H., Kapur, R., and Boman,
H. G. (1982) Insect immunity: isolation and structure of cecropin D
and four minor antibacterial components from Cecropia pupae. Eur.
J. Biochem. 127, 207–217.
64. Carvalho, M. d. G. S., Shewmaker, P. L., Steigerwalt, A. G., Morey,
R. E., Sampson, A. J., Joyce, K., Barrett, T. J., Teixeira, L. M., and
Facklam, R. R. (2006) Enterococcus caccae sp. nov., isolated from
human stools. Int. J. Syst. Evol. Microbiol. 56, 1505–1508.
65. Jerabek, H., Pabst, G., Rappolt, M., and Stockner, T. (2010) Mem-
brane-mediated effect on ion channels induced by the anesthetic drug
ketamine. J. Am. Chem. Soc. 132, 7990–7997.
66. Wolf, M. G., Hoefling, M., Aponte-Santamaria, C., Grubmuller, H.,
and Groenhof, G. (2010) g_membed: efficient insertion of a mem-
brane protein into an equilibrated lipid bilayer with minimal pertur-
bation. J. Comput. Chem. 31, 2169–2174.
67. Berger, O., Edholm, O., and Jahnig, F. (1997) Molecular dynamics
simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at
full hydration, constant pressure, and constant temperature. Biophys.
J. 72, 2002–2013.
68. Berendsen, H. J., Postma, J. P. M., van Gunsteren, W. F., and
Hermans, J. (1981) Intermol. Forces, 331–342.
69. Hess, B., Kutzner, C., van der Spoel, D., and Lindahl, E. (2008)
GROMACS 4: algorithms for highly efficient, load-balanced, and
scalable molecular simulation. J. Chem. Theor. Comput. 4, 435–447.
70. Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E.,
and Berendsen, H. J. (2005) GROMACS: fast, flexible, and free.
J. Comput. Chem. 26, 1701–1718.
71. Bussi,G.,Donadio,D.,andParrinello,M.(2007)Canonicalsampling
through velocity rescaling. J. Chem. Phys. 126, 014101.
72. Berendsen, H. J. C., Postma, J. P. M., Vangunsteren, W. F., Dinola,
A., and Haak, J. R. (1984) Molecular-dynamics with coupling to an
external bath. J. Chem. Phys. 81, 3684–3690.
73. Hess, B., Bekker, H., Berendsen, H. J. C., and Fraaije, J. G. E. M.
(1997) LINCS: A linear constraint solver for molecular simulations.
J. Comput. Chem. 18, 1463–1472.
74. Darden, T., York, D., and Pedersen, L. (1993) Particle mesh Ewald;
an N.Log(N)methodforEwald sumsinlarge systems. J. Chem. Phys.
98, 10089–10092.
75. W€ uthrich, K. (1986) NMR of Proteins and Nucleic Acids, Wiley, New
York.
76. Franzmann, M., Otzen, D., and Wimmer, R. (2009) Quantitative use
of paramagnetic relaxation enhancements for determining orienta-
tions and insertion depths of peptides in micelles. ChemBioChem 10,
2339–2347.
77. Pintacuda,G.,andOtting,G.(2002)Identificationofproteinsurfaces
by NMR measurements with a pramagnetic Gd(III) chelate. J. Am.
Chem. Soc. 124, 372–373.
78. Zangger,K.,Respondek,M.,Gobl,C.,Hohlweg,W.,Rasmussen,K.,
Grampp, G., and Madl, T. (2009) Positioning of micelle-bound
peptides by paramagnetic relaxation enhancements. J. Phys. Chem.
B 113, 4400–4406.
79. Kabsch, W., and Sander, C. (1983) Dictionary of protein secondary
structure: pattern recognition of hydrogen-bonded and geometrical
features. Biopolymers 22, 2577–2637.
80. Hofmann, K., and Stoffel, W. (1993) TMbase;a database of mem-
brane spanning proteins segments. Biol. Chem. Hoppe-Seyler 374,
166.
81. Drider,D.,Fimland,G.,Hechard,Y.,McMullen,L.M.,andPrevost,
H. (2006) The continuing story of class IIa bacteriocins. Microbiol.
Mol. Biol. Rev. 70, 564–582.
82. Boman, H. G. (2000) Innate immunity and the normal microflora.
Immunol. Rev. 173, 5–16.
83. Hancock,R.E.,andLehrer,R.(1998)Cationicpeptides:anewsource
of antibiotics. Trends Biotechnol. 16, 82–88.
84. Casaus,P.,Nilsen, T.,Cintas, L.M., Nes, I.F.,Hernandez,P.E., and
Holo, H. (1997) Enterocin B, a new bacteriocin from Enterococcus
faecium T136 which can act synergistically with enterocin A. Micro-
biology 143 (Part 7), 2287–2294.
85. Clewell, D. B. (2007) Properties of Enterococcus faecalis plasmid
pAD1, a member of a widely disseminated family of pheromone-
responding, conjugative, virulence elements encoding cytolysin. Plas-
mid 58, 205–227.
86. Brogden, K. A. (2005) Antimicrobial peptides: pore formers or
metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3, 238–250.
87. Jenssen, H., Hamill, P., and Hancock, R. E. (2006) Peptide antimi-
crobial agents. Clin. Microbiol. Rev. 19, 491–511.
88. Shai, Y. (1999) Mechanism of the binding, insertion and destabiliza-
tion of phospholipid bilayer membranes by alpha-helical antimicro-
bialandcellnon-selectivemembrane-lyticpeptides.Biochim.Biophys.
Acta 1462, 55–70.
89. Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms.
Nature 415, 389–395.
90. Dyson, H. J., and Wright, P. E. (2005) Intrinsically unstructured
proteins and their functions. Nat. Rev. Mol. Cell. Biol. 6, 197–208.